Literature DB >> 12370525

Rectal applications of nonoxynol-9 cause tissue disruption in a monkey model.

Dorothy L Patton1, Yvonne T Cosgrove Sweeney, Lorna K Rabe, Sharon L Hillier.   

Abstract

BACKGROUND: Efforts to develop topical microbicide products have all but ignored evaluation for rectal use. GOAL: The goal of this study was to assess the effects of multiple rectal applications of Conceptrol (containing 4% nonoxynol-9) on flora and mucosal tissues in the pig-tailed macaque model. STUDY
DESIGN: Monkeys (8 per group) received daily rectal applications of Conceptrol, placebo gel, or no product, for 3 days. At each visit, a preapplication rectal lavage specimen and swab specimen for microbiology and pH determination were collected. Conceptrol or placebo gel (2.5 ml) was then administered intrarectally. Fifteen minutes after application, samples were again collected.
RESULTS: Gross observation of rectal lavage indicated sheets of epithelium 15 minutes after application of the nonoxynol-9 product. Histopathology of these samples revealed epithelial sheets with stroma attached. The presence of H(2)O(2)-producing lactobacilli remained relatively constant, whereas that of H(2)O(2)-producing viridans streptococci diminished in all nonoxynol-9-exposed animals in which these organisms were detected at baseline.
CONCLUSIONS: Repeated applications of nonoxynol-9 disrupts the rectal mucosa of the pig-tailed macaque. The disruption of these tissues could have serious implications for an increase in likelihood of acquisition of sexually transmitted infection/HIV in humans.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12370525     DOI: 10.1097/00007435-200210000-00004

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  25 in total

1.  Retrocyclin RC-101 blocks HIV-1 transmission across cervical mucosa in an organ culture.

Authors:  Phalguni Gupta; Deena Ratner; Ming Ding; Bruce Patterson; Lisa C Rohan; Todd A Reinhart; Velpandi Ayyavoo; Xioli Huang; Dorothy L Patton; Bharat Ramratnam; Alexander M Cole
Journal:  J Acquir Immune Defic Syndr       Date:  2012-08-15       Impact factor: 3.731

2.  Critical design features of phenyl carboxylate-containing polymer microbicides.

Authors:  Robert F Rando; Sakae Obara; Mark C Osterling; Marie Mankowski; Shendra R Miller; Mary L Ferguson; Fred C Krebs; Brian Wigdahl; Mohamed Labib; Hiroyasu Kokubo
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

3.  Enhanced in vitro transcytosis of simian immunodeficiency virus mediated by vaccine-induced antibody predicts transmitted/founder strain number after rectal challenge.

Authors:  Sandeep Gupta; Poonam Pegu; David J Venzon; Johannes S Gach; Zhong-Min Ma; Gary Landucci; Christopher J Miller; Genoveffa Franchini; Donald N Forthal
Journal:  J Infect Dis       Date:  2014-05-21       Impact factor: 5.226

4.  Topical injury evaluation of the murine colorectal mucosa using confocal endomicrosopy: a valuable method for assessing mucosal injuries associated with risk of pathogen transmission.

Authors:  Gracie Vargas; Kathleen Listiak Vincent; Jingna Wei; Nigel Bourne; Massoud Motamedi
Journal:  J Microsc       Date:  2016-06-28       Impact factor: 1.758

5.  Image-based noninvasive evaluation of colorectal mucosal injury in sheep after topical application of microbicides.

Authors:  Kathleen Listiak Vincent; Gracie Vargas; Nigel Bourne; Valerie Galvan-Turner; Jamal I Saada; Gabriel H Lee; Elena Sbrana; Massoud Motamedi
Journal:  Sex Transm Dis       Date:  2013-11       Impact factor: 2.830

6.  Anorectal sexually transmitted infections in men who have sex with men--special considerations for clinicians.

Authors:  Stephen E Goldstone; Mark L Welton
Journal:  Clin Colon Rectal Surg       Date:  2004-11

7.  In vitro comparison of topical microbicides for prevention of human immunodeficiency virus type 1 transmission.

Authors:  Charlene S Dezzutti; V Nicole James; Artur Ramos; Sharon T Sullivan; Aladin Siddig; Timothy J Bush; Lisa A Grohskopf; Lynn Paxton; Shambavi Subbarao; Clyde E Hart
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

8.  In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide.

Authors:  Lisa C Rohan; Bernard J Moncla; Ratiya Pamela Kunjara Na Ayudhya; Marilyn Cost; Yunda Huang; Fang Gai; Nicole Billitto; J D Lynam; Kara Pryke; Phillip Graebing; Nicole Hopkins; James F Rooney; David Friend; Charlene S Dezzutti
Journal:  PLoS One       Date:  2010-02-19       Impact factor: 3.240

9.  In Vivo Rectal Mucosal Barrier Function Imaging in a Large-Animal Model by Using Confocal Endomicroscopy: Implications for Injury Assessment and Use in HIV Prevention Studies.

Authors:  Gracie Vargas; Kathleen Listiak Vincent; Yong Zhu; David Szafron; Tyra Caitlin Brown; Paula Patricia Villarreal; Nigel Bourne; Gregg N Milligan; Massoud Motamedi
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

10.  Microbicide safety/efficacy studies in animals: macaques and small animal models.

Authors:  Ronald S Veazey
Journal:  Curr Opin HIV AIDS       Date:  2008-09       Impact factor: 4.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.